BSE Live
Nov 17, 16:01Prev. Close
713.00
Open Price
710.05
Bid Price (Qty.)
724.00 (1)
Offer Price (Qty.)
729.15 (4)
NSE Live
Nov 17, 15:59Prev. Close
713.20
Open Price
713.15
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
729.00 (83)
| Key Financial Ratios of Aarti Pharmalabs (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
| Per Share Ratios | |||||
| Basic EPS (Rs.) | 30.06 | 23.93 | 21.35 | 13.49 | |
| Diluted EPS (Rs.) | 30.04 | 23.93 | 21.35 | 13.49 | |
| Cash EPS (Rs.) | 39.64 | 32.01 | 28.25 | 36.08 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 219.55 | 193.88 | 171.97 | 304.30 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 219.55 | 193.88 | 171.97 | 304.30 | |
| Revenue from Operations/Share (Rs.) | 233.36 | 204.42 | 214.64 | 263.36 | |
| PBDIT/Share (Rs.) | 52.35 | 43.14 | 38.00 | 45.97 | |
| PBIT/Share (Rs.) | 42.76 | 35.06 | 31.10 | 36.73 | |
| PBT/Share (Rs.) | 39.80 | 33.16 | 28.77 | 34.10 | |
| Net Profit/Share (Rs.) | 30.06 | 23.93 | 21.35 | 26.83 | |
| NP After MI And SOA / Share (Rs.) | 30.06 | 23.93 | 21.35 | 26.83 | |
| Profitability Ratios | |||||
| PBDIT Margin (%) | 22.43 | 21.10 | 17.70 | 17.45 | |
| PBIT Margin (%) | 18.32 | 17.14 | 14.48 | 13.94 | |
| PBT Margin (%) | 17.05 | 16.21 | 13.40 | 12.94 | |
| Net Profit Margin (%) | 12.87 | 11.70 | 9.94 | 10.18 | |
| NP After MI And SOA Margin (%) | 12.87 | 11.70 | 9.94 | 10.18 | |
| Return on Networth/Equity (%) | 13.68 | 12.34 | 12.41 | 8.81 | |
| Return on Capital Employed (%) | 17.23 | 16.83 | 17.19 | 11.46 | |
| Return on Assets (%) | 9.37 | 8.40 | 8.67 | 5.99 | |
| Total Debt/Equity (X) | 0.20 | 0.15 | 0.14 | 0.24 | |
| Asset Turnover Ratio (%) | 0.77 | 0.77 | 0.76 | 0.00 | |
| Liquidity Ratios | |||||
| Current Ratio (X) | 2.01 | 1.94 | 1.95 | 1.77 | |
| Quick Ratio (X) | 1.12 | 1.01 | 0.94 | 0.95 | |
| Inventory Turnover Ratio (X) | 3.44 | 1.38 | 1.78 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 11.64 | 8.35 | 10.04 | 2.02 | |
| Dividend Payout Ratio (CP) (%) | 8.82 | 6.24 | 7.59 | 1.50 | |
| Earnings Retention Ratio (%) | 88.36 | 91.65 | 89.96 | 97.98 | |
| Cash Earnings Retention Ratio (%) | 91.18 | 93.76 | 92.41 | 98.50 | |
| Coverage Ratios | |||||
| Interest Coverage Ratios (%) | 17.64 | 22.71 | 16.36 | 17.52 | |
| Interest Coverage Ratios (Post Tax) (%) | 17.64 | 22.71 | 16.36 | 17.52 | |
| Valuation Ratios | |||||
| Enterprise Value (Cr.) | 7,172.16 | 4,182.27 | 2,678.01 | 0.00 | |
| EV/Net Operating Revenue (X) | 3.39 | 2.26 | 1.38 | 0.00 | |
| EV/EBITDA (X) | 15.12 | 10.70 | 7.78 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 3.21 | 2.13 | 1.28 | 0.00 | |
| Retention Ratios (%) | 88.35 | 91.64 | 89.95 | 97.97 | |
| Price/BV (X) | 3.41 | 2.24 | 1.60 | 0.00 | |
| Price/Net Operating Revenue | 3.21 | 2.13 | 1.28 | 0.00 | |
| Earnings Yield | 0.04 | 0.06 | 0.08 | 0.00 |
14.11.2025
AARTIPHARM Consolidated September 2025 Net Sales at Rs 418.33 crore, down 8.67% Y-o-Y
12.11.2025
AARTIPHARM Standalone September 2025 Net Sales at Rs 417.29 crore, up 10.6% Y-o-Y
22.09.2025
19.09.2025
14.11.2025
AARTIPHARM Consolidated September 2025 Net Sales at Rs 418.33 crore, down 8.67% Y-o-Y
12.11.2025
AARTIPHARM Standalone September 2025 Net Sales at Rs 417.29 crore, up 10.6% Y-o-Y
15.05.2025
AARTIPHARM Standalone March 2025 Net Sales at Rs 529.62 crore, up 27.68% Y-o-Y
12.05.2025
AARTIPHARM Consolidated March 2025 Net Sales at Rs 563.78 crore, up 11.47% Y-o-Y